US FDA-Funded Heart Failure Study To Focus On Patient-Centric Outcomes
Executive Summary
Heart failure drugs do not require favorable effect on survival or hospitalization for approval, US FDA says; correlation between physical function and physiology biomarkers and clinical endpoints to be measured in upcoming clinical trial examining feasibility of capturing patient-centric data.